Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 13, 2026 20:30 ET | Source: BioRestorative Therapies, Inc

BioRestorative Announces Closing of $5.0 Million Public Offering

MELVILLE, N.Y., Feb. 13, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a late stage clinical regenerative medicine innovator...
August 21, 2024 10:50 ET | Source: Schall Law

Investors Have Opportunity to Lead Late Stage Asset Management, LLC Securities Fraud Lawsuit with the Schall Law Firm

Investors Have Opportunity to Lead Late Stage Asset Management, LLC Securities Fraud Lawsuit with the Schall Law Firm
August 14, 2024 11:30 ET | Source: Schall Law

Investors Have Opportunity to Lead Late Stage Asset Management, LLC Securities Fraud Lawsuit with the Schall Law Firm

Investors Have Opportunity to Lead Late Stage Asset Management, LLC Securities Fraud Lawsuit with the Schall Law Firm
August 07, 2024 12:20 ET | Source: Schall Law

Investors Have Opportunity to Lead Late Stage Asset Management, LLC Securities Fraud Lawsuit with the Schall Law Firm

Investors Have Opportunity to Lead Late Stage Asset Management, LLC Securities Fraud Lawsuit with the Schall Law Firm
May 31, 2024 08:36 ET | Source: Ocugen

Data and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation in OCU410 ArMaDa study for Geographic Atrophy

Established Medium Dose as Safe and Tolerable Dose in Current OCU410 Clinical TrialDSMB Recommends Continuing with High-Dose Cohort Dosing with Concurrent Phase 2 Dosing MALVERN, Pa., May 31, 2024 ...
October 30, 2020 06:00 ET | Source: Cromos Pharma; Avance Clinical

Euro-Australian collaboration offers scalable solutions for biotech: announced at Bio-Europe 2020

DUBLIN, Ireland and ADELAIDE, Australia, Oct. 30, 2020 (GLOBE NEWSWIRE) -- Two dominant regional contract research organizations (CRO), Avance Clinical and Cromos Pharma, with operations in...
September 09, 2014 13:00 ET | Source: Blue Cloud Ventures

Blue Cloud Ventures Announces Success of First Fund

NEW YORK, NY--(Marketwired - Sep 9, 2014) - Blue Cloud Ventures (BCV), a growth and late stage co-investment fund that focuses on cloud-based enterprise software companies, announced today the...